Hexapeptide-11
Skin / Anti-AgingAlso known as: Peptamide-6
Mechanism
A peptide derived from yeast fermentation that helps skin cells multiply and stay firm. It stimulates both keratinocytes (surface skin cells) and fibroblasts (collagen-producing cells), improving firmness and elasticity. Works well alongside vitamin C and retinol in anti-aging formulations.
Technical detail
Hexapeptide derived from Saccharomyces cerevisiae fermentation. Stimulates keratinocyte and fibroblast proliferation via MAPK/ERK signaling pathway activation. Increases expression of integrins (alpha-2, beta-1) involved in cell-matrix adhesion, improving dermal-epidermal cohesion. In-vitro studies show 40-80% increase in fibroblast proliferation at optimal concentrations. Synergistic effects documented with ascorbic acid (enhanced collagen hydroxylation) and retinoids (complementary gene transcription effects). Improves skin firmness, elasticity, and moisture retention metrics.
Effects
## Integumentary System — Skin Firmness and Extracellular Matrix [Tier 3 — Limited Human Data] Hexapeptide-11 is a yeast-derived peptide (from Saccharomyces cerevisiae ferment) that promotes extracellular matrix (ECM) protein synthesis in dermal fibroblasts. It upregulates collagen type I, type III, and fibronectin production via activation of TGF-beta signaling pathways. In manufacturer-sponsored studies, Hexapeptide-11 improved skin firmness by 14-22% (measured by cutometry) and skin elasticity by 8-16% after 56 days of twice-daily application. Unlike collagen-stimulating peptides that work via specific receptor targets (GHK-Cu via integrins, Matrixyl via growth factor receptor transactivation), Hexapeptide-11 appears to work through a broader ECM-remodeling signal. ## Wound Healing and Tissue Repair [Tier 3 — In Vitro Data] In vitro studies show Hexapeptide-11 accelerates fibroblast migration and proliferation, key steps in wound healing. It also upregulates hyaluronic acid synthase (HAS) expression, increasing endogenous hyaluronic acid production in dermal tissue.
Practitioner Guide
## Practical Formulation Guide ### Effective Concentrations - **Manufacturer-recommended use level:** 1-5% of commercial solution in finished product. - **Common finished-product range:** 0.001-0.01% active peptide. ### Formulation Considerations - **pH:** Stable across typical cosmetic pH range (pH 4.0-7.0). - **Compatibility:** Compatible with all common cosmetic peptides. Works synergistically with Matrixyl (both stimulate collagen but through different signaling pathways). - **Best applications:** Anti-aging serums targeting firmness and elasticity. Body firming products. Post-menopausal skin thinning. - **Vehicle:** Aqueous serums preferred. Compatible with emulsions and gels. ### Layering in a Multi-Peptide Serum Hexapeptide-11 works well as part of a comprehensive collagen-support protocol: 1. Argireline (expression line relaxation) 2. Hexapeptide-11 (ECM/firmness support) 3. Matrixyl (collagen stimulation) 4. Palmitoyl-Tripeptide-1 (GHK pathway for collagen and remodeling) These four can be combined in a single formulation without compatibility issues. ### Realistic Expectations - **4 weeks:** Subtle improvement in skin texture and hydration. Firmness changes not yet measurable. - **8 weeks:** 10-15% improvement in cutometry (firmness) measurements. Users may notice skin "feels tighter." - **12 weeks:** Maximum expected benefit of ~20% firmness improvement. This is a modest but real improvement, noticeable primarily in before/after photography rather than day-to-day perception.
Research Summary
## Tier 1 — Strong Clinical Evidence - None. Cosmeceutical ingredient, not a drug. ## Tier 2 — Moderate Evidence - Manufacturer-sponsored clinical studies showing 14-22% improvement in skin firmness (cutometry) and 8-16% improvement in elasticity after 56 days (n=20-30) - Instrumental measurements with validated devices (Cutometer, Reviscometer) ## Tier 3 — Preclinical/Theoretical - In vitro fibroblast studies demonstrating upregulation of collagen I, III, and fibronectin - TGF-beta pathway activation confirmed in cell culture - Hyaluronic acid synthase upregulation in dermal fibroblasts - Limited independent validation — most data from ingredient manufacturer - Mechanism of action less precisely characterized than other peptides (Matrixyl, GHK-Cu)